{
  "ticker": "NVCR",
  "company_name": "NovoCure Limited",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT00749346",
      "title": "NovoTTF-100L in Combination With Pemetrexed (Alimta\u00ae) for Advanced Non-small Cell Lung Cancer",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Non-small Cell Lung Cancer, NSCLC",
      "start_date": "2008-05",
      "completion_date": "2011-07",
      "enrollment": 0,
      "sponsor": "NovoCure Ltd."
    },
    {
      "nct_id": "NCT01756729",
      "title": "Post-approval Study of NovoTTF-100A in Recurrent GBM Patients",
      "status": "TERMINATED",
      "phase": "PHASE4",
      "condition": "Recurrent Glioblastoma Multiforme",
      "start_date": "2012-12",
      "completion_date": "2018-01",
      "enrollment": 0,
      "sponsor": "NovoCure Ltd."
    },
    {
      "nct_id": "NCT03477110",
      "title": "Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma",
      "status": "COMPLETED",
      "phase": "EARLY_PHASE1",
      "condition": "Glioblastoma",
      "start_date": "2018-05-04",
      "completion_date": "2024-01-26",
      "enrollment": 0,
      "sponsor": "Sidney Kimmel Cancer Center at Thomas Jefferson University"
    },
    {
      "nct_id": "NCT02893137",
      "title": "Enhancing Optune Therapy With Targeted Craniectomy",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Glioblastoma",
      "start_date": "2016-10-01",
      "completion_date": "2019-05-31",
      "enrollment": 0,
      "sponsor": "Aarhus University Hospital"
    },
    {
      "nct_id": "NCT02397928",
      "title": "Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Malignant Pleural Mesothelioma",
      "start_date": "2015-02",
      "completion_date": "2018-04",
      "enrollment": 0,
      "sponsor": "NovoCure Ltd."
    },
    {
      "nct_id": "NCT03430791",
      "title": "Trial of Combination Tumor Treating Fields (TTF; Optune), Nivolumab Plus/Minus Ipilimumab for Recurrent Glioblastoma",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Recurrent Glioblastoma",
      "start_date": "2018-12-05",
      "completion_date": "2021-01-27",
      "enrollment": 0,
      "sponsor": "Baptist Health South Florida"
    },
    {
      "nct_id": "NCT03995667",
      "title": "Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung Cancer",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8, Stage IA2 Lung Cancer AJCC v8, Stage IA3 Lung Cancer AJCC v8, Stage IB Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8, Stage IIB Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVB Lung Cancer AJCC v8",
      "start_date": "2019-06-11",
      "completion_date": "2022-08-04",
      "enrollment": 0,
      "sponsor": "OHSU Knight Cancer Institute"
    },
    {
      "nct_id": "NCT03223103",
      "title": "Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1",
      "condition": "Glioblastoma",
      "start_date": "2018-03-01",
      "completion_date": "2029-05-12",
      "enrollment": 0,
      "sponsor": "Adilia Hormigo"
    },
    {
      "nct_id": "NCT06216301",
      "title": "LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Metastatic Non-small Cell Lung Cancer",
      "start_date": "2024-07-31",
      "completion_date": "2028-10",
      "enrollment": 0,
      "sponsor": "NovoCure GmbH"
    },
    {
      "nct_id": "NCT04474353",
      "title": "Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Glioblastoma, Newly Diagnosed Glioblastoma",
      "start_date": "2021-05-21",
      "completion_date": "2025-09-02",
      "enrollment": 0,
      "sponsor": "Stanford University"
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "PHASE1, PHASE2": 4,
      "PHASE4": 1,
      "EARLY_PHASE1": 4,
      "PHASE1": 6,
      "PHASE2": 10,
      "PHASE3": 4,
      "": 7,
      "NA": 14
    },
    "by_status": {
      "COMPLETED": 13,
      "TERMINATED": 11,
      "ACTIVE_NOT_RECRUITING": 4,
      "RECRUITING": 9,
      "WITHDRAWN": 4,
      "UNKNOWN": 6,
      "NOT_YET_RECRUITING": 2,
      "TEMPORARILY_NOT_AVAILABLE": 1
    },
    "active_trials": 13,
    "completed_trials": 13,
    "conditions": [
      "1-5 Brain Metastases From Non-Small Cell Lung Cancer",
      "Anaplastic (Malignant) Meningioma, Atypical Meningioma, Grade II Meningioma, Grade III Meningioma, Recurrent Meningioma, Supratentorial Meningioma",
      "Anaplastic Oligodendroglioma, Oligoastrocytoma, Oligodendroglioma",
      "Astrocytoma, Grade II, Astrocytoma, Grade III",
      "Astrocytoma, Grade III",
      "Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma",
      "Brain Metastases, Small Cell Lung Cancer",
      "Central Nervous System Neoplasms, Primary",
      "Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8, Stage IA2 Lung Cancer AJCC v8, Stage IA3 Lung Cancer AJCC v8, Stage IB Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8, Stage IIB Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVB Lung Cancer AJCC v8",
      "Extensive Stage Small Cell Lung Carcinoma",
      "Glioblastoma",
      "Glioblastoma Multiforme",
      "Glioblastoma Multiforme, Glioblastoma, Malignant Glioma, GBM",
      "Glioblastoma, Glioblastoma Multiforme",
      "Glioblastoma, Glioma, Gliosarcoma",
      "Glioblastoma, Newly Diagnosed Glioblastoma",
      "Glioma",
      "High Grade Glioma, Ependymoma",
      "Locally Advanced Pancreatic Adenocarcinoma",
      "Lung Cancer, Esophageal Cancer, Mesothelioma; Lung",
      "Malignant Glioma",
      "Malignant Glioma, Ependymoma, Diffuse Intrinsic Pontine Glioma",
      "Malignant Pleural Mesothelioma",
      "Melanoma With Brain Metastasis",
      "Metastatic Melanoma, Melanoma Brain Metastasis",
      "Metastatic Non-small Cell Lung Cancer",
      "NSCLC, Non Small Cell Lung Cancer",
      "Non-small Cell Lung Cancer, NSCLC",
      "Ovarian Cancer",
      "Ovarian Carcinoma",
      "Pancreas Adenocarcinoma",
      "Pancreas Cancer, Locally Advanced, Locally Advanced Pancreatic Adenocarcinoma",
      "Pancreas Cancer, Metastatic Pancreatic Cancer, Pancreatic Adenocarcinoma, Metastatic Adenocarcinoma",
      "Pleural Mesothelioma",
      "RECURRENT GLIOBLASTOMA, Brain Tumor",
      "Recurrent Glioblastoma",
      "Recurrent Glioblastoma Multiforme",
      "Spinal Metastasis",
      "Uveal Melanoma"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:20:28.463434",
    "search_query": "NovoCure Limited",
    "url": "https://clinicaltrials.gov/search?term=NovoCure+Limited"
  }
}